Mitochondrial ATP Synthase in Cardiac Biology and Disease

线粒体 ATP 合酶在心脏生物学和疾病中的作用

基本信息

  • 批准号:
    10758687
  • 负责人:
  • 金额:
    $ 2.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-06-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

We have created two independent mouse models of adult cardiomyocyte-specific mitochondrial ATP synthase deficiency: cardiomyocyte-specific ATP5L knockout (KO) mice and cardiomyocyte-specific ATP5J KO mice. Analysis of both models have shown that mice with ~90% depletion of the mitochondrial ATP synthase unexpectedly remain healthy with normal cardiac function for several weeks before transitioning to lethal heart failure with reduced ejection fraction (HFrEF). Studies in the parent grant are investigating the compensatory mechanisms that maintain cardiac function in the face of severe mitochondrial ATP synthase depletion in cardiomyocytes and the mechanisms that eventually mediate the transition to heart failure which, interestingly, do not appear to involve further deterioration of cardiac energetics. Given the traditional view that the mitochondrial ATP synthesis is essential to sustain energetics in mammalian cells – especially energy- demanding cells such as cardiomyocytes – it is surprising that ~10% of its usual levels in cardiomyocytes are adequate to sustain basal mouse health and cardiac function. Our results suggest that the full complement of mitochondrial ATP synthase in cardiomyocytes is not needed at rest. This observation raises the question as to how much of the mitochondrial ATP synthase is needed in cardiomyocytes to sustain cardiac function under more energetically demanding conditions, a question that could not be previously addressed without these mouse models. To answer this question, it is necessary to impose a physiological stress on the mice that increases the energetic demands of cardiomyocytes – but without simultaneously activating pathological stress pathways. We have chosen to use acute β-adrenergic stimulation with isoproterenol and, independently, acute exercise. A second objective of the Supplement is to deepen our baseline characterization of the ATP5J KO mice, which were generated by the candidate. The baseline characterization of the ATP5L KO mice is already complete. However, studies performed after the parent grant was funded, show that the ATP5J KO mice appear to have an accelerated phenotype. Hence, these mice need a thorough baseline characterization. Thus, the specific aims are: 1. To extend the baseline characterization of the cardiomyocyte-specific ATP5J knockout mice. 2. To assess the response of cardiomyocyte-specific ATP5L KO and ATP5J KO mouse lines to physiological stimuli that increase cardiomyocyte energetic demands. The scientific questions addressed in this Supplement are directly related to those of the parent grant and the resulting information will enhance our understanding of the findings of the parent grant. However, both the proposed work in the Supplement and the personnel required to perform it are distinct from that in the parent grant.
我们建立了两个独立的成年心肌细胞特异性线粒体ATP合酶小鼠模型 缺乏:心肌细胞特异性ATP 5L敲除(KO)小鼠和心肌细胞特异性ATP 5 J KO小鼠。 对两种模型的分析表明,线粒体ATP合酶缺失约90%的小鼠, 在转变为致命心脏病之前,意外地保持健康,心脏功能正常数周 射血分数降低(HFrEF)。对父母补助金的研究正在调查 在严重线粒体ATP合酶耗竭的情况下维持心脏功能的机制 心肌细胞和最终介导心力衰竭转变的机制,有趣的是, 似乎并不涉及心脏能量学的进一步恶化。鉴于传统观点认为 线粒体ATP的合成是维持哺乳动物细胞能量-特别是能量- 要求细胞,如心肌细胞-令人惊讶的是,在心肌细胞中约10%的正常水平, 足以维持小鼠的基本健康和心脏功能。我们的研究结果表明, 心肌细胞中的线粒体ATP合酶在休息时不需要。这一观察提出了一个问题, 心肌细胞需要多少线粒体ATP合酶来维持心脏功能, 更积极的要求条件,一个问题,不能以前解决没有这些 小鼠模型。为了回答这个问题,有必要对小鼠施加生理压力, 增加心肌细胞的能量需求-但不会同时激活病理性应激 途径。我们选择用异丙肾上腺素进行急性β肾上腺素能刺激, 锻炼的补充的第二个目标是深化我们对ATP 5 J KO的基线表征 小鼠,由候选人产生。ATP 5L KO小鼠的基线表征已经是 完成.然而,在父母资助后进行的研究表明,ATP 5 J KO小鼠似乎 有一个加速表型。因此,这些小鼠需要彻底的基线表征。因此 具体目标是:1.扩展心肌细胞特异性ATP 5 J敲除小鼠的基线表征。 2.为了评估心肌细胞特异性ATP 5L KO和ATP 5 J KO小鼠系对生理性心肌保护的反应, 增加心肌细胞能量需求的刺激。本补编所述的科学问题 与父母补助金直接相关,由此产生的信息将有助于我们了解 家长补助金的调查结果然而,补编中拟议的工作和所需人员 这是一个与父母不同的地方。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard N Kitsis其他文献

Eat your heart out
羡慕死你。
  • DOI:
    10.1038/nm0507-539
  • 发表时间:
    2007-05-01
  • 期刊:
  • 影响因子:
    50.000
  • 作者:
    Richard N Kitsis;Chang-Fu Peng;Ana Maria Cuervo
  • 通讯作者:
    Ana Maria Cuervo

Richard N Kitsis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard N Kitsis', 18)}}的其他基金

Mitochondrial ATP Synthase in Cardiac Biology and Disease
线粒体 ATP 合酶在心脏生物学和疾病中的作用
  • 批准号:
    10632143
  • 财政年份:
    2022
  • 资助金额:
    $ 2.05万
  • 项目类别:
Caspase-9 as a nodal point connecting necrotic and apoptotic cell death in myocardial infarction
Caspase-9作为连接心肌梗死细胞坏死和凋亡的节点
  • 批准号:
    10666668
  • 财政年份:
    2022
  • 资助金额:
    $ 2.05万
  • 项目类别:
Caspase-9 as a nodal point connecting necrotic and apoptotic cell death in myocardial infarction
Caspase-9 作为连接心肌梗死细胞坏死和凋亡的节点
  • 批准号:
    10504387
  • 财政年份:
    2022
  • 资助金额:
    $ 2.05万
  • 项目类别:
Mitochondrial ATP Synthase in Cardiac Biology and Disease
线粒体 ATP 合酶在心脏生物学和疾病中的作用
  • 批准号:
    10812556
  • 财政年份:
    2022
  • 资助金额:
    $ 2.05万
  • 项目类别:
Mitochondrial ATP Synthase in Cardiac Biology and Disease
线粒体 ATP 合酶在心脏生物学和疾病中的作用
  • 批准号:
    10446745
  • 财政年份:
    2022
  • 资助金额:
    $ 2.05万
  • 项目类别:
Modulation of Mitofusin Activity to Treat Heart Disease
调节丝裂霉素活性治疗心脏病
  • 批准号:
    10280485
  • 财政年份:
    2021
  • 资助金额:
    $ 2.05万
  • 项目类别:
Modulation of Mitofusin Activity to Treat Heart Disease
调节丝裂霉素活性治疗心脏病
  • 批准号:
    10458699
  • 财政年份:
    2021
  • 资助金额:
    $ 2.05万
  • 项目类别:
Modulation of Mitofusin Activity to Treat Heart Disease
调节丝裂霉素活性治疗心脏病
  • 批准号:
    10655447
  • 财政年份:
    2021
  • 资助金额:
    $ 2.05万
  • 项目类别:
Mechanisms of cardiovascular disease
心血管疾病的机制
  • 批准号:
    10546496
  • 财政年份:
    2019
  • 资助金额:
    $ 2.05万
  • 项目类别:
Mechanisms of cardiovascular disease
心血管疾病的机制
  • 批准号:
    9908028
  • 财政年份:
    2019
  • 资助金额:
    $ 2.05万
  • 项目类别:

相似海外基金

SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
  • 批准号:
    2400967
  • 财政年份:
    2024
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328975
  • 财政年份:
    2024
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
  • 批准号:
    NE/Y000080/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
  • 批准号:
    10112700
  • 财政年份:
    2024
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328973
  • 财政年份:
    2024
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328972
  • 财政年份:
    2024
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332916
  • 财政年份:
    2024
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332917
  • 财政年份:
    2024
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328974
  • 财政年份:
    2024
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Continuing Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
  • 批准号:
    2307983
  • 财政年份:
    2023
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了